Olmesartan Medoxomil 20/20 mg

Adult dose

Olmesartan Medoxomil: The recommended starting dose is 10 mg once daily, taken regardless of meals. If blood pressure is not adequately controlled, it may be increased to 20 mg once daily, with a maximum of 40 mg possible. The blood pressure-lowering effect is observed within 2 weeks of starting treatment, and the maximum effect occurs after approximately 8 weeks. Rosuvastatin: The starting dose is 5 mg once daily, adjustable as necessary to maintain the target dose.

Child dose

Safety and efficacy for children under 18 years of age have not been established.

This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, therefore, it should be discontinued immediately upon confirmation of pregnancy. People who are allergic to this medication or its components, pregnant or potentially pregnant women, or women who are nursing should not take this medication. Patients with very poor kidney function or undergoing kidney dialysis, severe liver disease, biliary obstruction, or with muscle disorders should also avoid this medication. Patients with low blood pressure or low body sodium, unstable kidney function, or at risk for hyperkalemia should exercise special caution when taking this medication, and should regularly check their condition through blood tests. This medication can cause muscle pain or weakness, and rarely severe muscle breakdown, so any abnormalities in the muscles should be reported to healthcare professionals immediately. Furthermore, this medication may affect liver function, so regular liver function tests should be performed before and during treatment. Avoid alcohol consumption during treatment, and exercise extra caution if there is a history of liver disease. Dizziness or drowsiness may occur, so caution should be taken when driving or operating hazardous machinery. This medication may interact with other drugs, so any other medications being taken should be disclosed to a doctor or pharmacist, particularly caution is advised when used in combination with potassium-sparing diuretics, lithium, and non-steroidal anti-inflammatory drugs. Women who are pregnant or planning to become pregnant should strictly use appropriate contraception, and immediately discontinue use upon confirmation of pregnancy. If nursing, this medication should be avoided due to potential effects on the baby, or breastfeeding should be discontinued. Safety and effectiveness have not been established for patients under 18 years of age. In case of overdose, symptoms such as hypotension and palpitations may occur, so immediate contact with healthcare professionals is necessary, and liver and muscle conditions should be carefully monitored. This medication should be kept out of reach of children and should not be transferred to other containers.

Serious side effects

Urticaria, angioedema, anaphylactic reaction, angioedema, rhabdomyolysis, hyperkalemia, acute renal failure, elevated serum creatinine, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, jaundice, hepatitis, autoimmune hepatitis, multiple organ dysfunction syndrome, viral pneumonia, severe skin reactions, severe allergic reactions, dyspnea, asthma attacks, severe neurological symptoms, heart

Mild side effects

• Headache
• dizziness
• reduced sensory perception
• drowsiness
• gastroesophageal reflux
• constipation
• cavities
• dyspepsia
• gastric ulcer
• gastritis

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1°C and 30°C. This will help maintain the effectiveness of the medication.

Appearance

White or yellowish round film-coated tablets

Package unit

30 tablets/box [30 tablets (10 tablets/Alu-Alu) × 3]